Sofosbuvir and velpatasvir
- Generic Name
- Sofosbuvir and velpatasvir
- Indication
1.用于治疗基因1～6型、混合型及未知型慢性丙型肝炎病毒(HCV) 的成人感染患者。
2.美国FDA批准用于治疗6岁及以上或体重超过17千克的6种基因型（GT-1,-2,-3,-4,-5,-6）的HCV儿童感染者（无肝硬化或轻度肝硬化）。
Hepatitis C Treatment in Idaho County Jails
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Eastern Idaho Public Health
- Target Recruit Count
- 100
- Registration Number
- NCT06533319
Eliminating HCV Infection Among PWUD
- Conditions
- Hepatitis C, ChronicDrug Use
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Vancouver Infectious Diseases Centre
- Target Recruit Count
- 300
- Registration Number
- NCT05474781
- Locations
- 🇨🇦
Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada
Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%
- Conditions
- Hepatitis C
- Interventions
- Device: Xpert HCV Viral load finger stick point of care test (Cepheid)Other: Standard of care
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Macfarlane Burnet Institute for Medical Research and Public Health Ltd
- Target Recruit Count
- 606
- Registration Number
- NCT05264558
- Locations
- 🇦🇺
Cairns and Hinterland Hospital and Health Service, Cairns, Queensland, Australia
Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
- Conditions
- Hepatitis C
- Interventions
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 318
- Registration Number
- NCT05248919
- Locations
- 🇵🇰
Clinical trials unit, Karachi, Sindh, Pakistan
SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients
- Conditions
- Hepatitis C
- Interventions
- First Posted Date
- 2021-07-02
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Target Recruit Count
- 150
- Registration Number
- NCT04948801
- Locations
- 🇨🇳
Deparment of Infectious Diseases, the Second Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
- Conditions
- Neoplasm RecurrenceHepatocellular CarcinomaHepatitis CTreatment Complication
- Interventions
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 84
- Registration Number
- NCT04653818
- Locations
- 🇪🇬
Alexandria University, Faculty of Medicine, Alexandria, Egypt
A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 201
- Registration Number
- NCT04075916
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Jackson Memorial Hospital/University of Miami, Miami, Florida, United States
Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil
- Conditions
- Chronic Hepatitis C
- Interventions
- Other: Telemedicine
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 144
- Registration Number
- NCT04039698
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil
The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 86
- Registration Number
- NCT03987503
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Micro-elimination of Hepatitis C Virus Infection in Uremics
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2020-07-10
- Target Recruit Count
- 135
- Registration Number
- NCT03891550
- Locations
- 🇨🇳
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.